文献速递生殖医学

自然增殖期冻融胚胎移植——一种可能便于安排周期且不影响妊娠结局的新方法

Natural proliferative phase frozen embryo transfer-a new approach which may facilitate scheduling without hindering pregnancy outcomes.
PubMed 文献 · Hum Reprod · 2024-01-01

单中心回顾性队列研究比较自然增殖期(NPP)、人工周期(AC)和自然周期(NC)三种内膜准备方案下冻融胚胎移植的活产率,纳入5791个周期。NPP组和NC组活产率均高于AC组,且早期妊娠出血率更低。作者认为NPP-FET可能是兼顾实用性与结局的有效安全替代方案。

要点

  • NPP-FET在增殖期内膜厚度≥7 mm且排除排卵后即开始阴道孕酮,无需考虑优势卵泡平均直径。
  • NPP组活产率49.1%,高于AC组38.4%(P<0.01),与NC组45.2%接近。
  • NPP组和NC组早期妊娠出血率分别为17.3%和14.7%,均低于AC组37.6%(P<0.01)。

核心结论

  • 本研究支持以下假设:与NC一样,NPP-FET在活产率方面可能优于AC。
  • 作者认为NPP-FET方案可能是NC和AC的有效且安全的替代方案,同时可提高患者随访和FET安排的实用性。
  • 作者指出需要进一步开展前瞻性研究,纳入更大且更同质的患者亚组来验证NPP-FET。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010年1月至2022年6月在一家私立不孕症中心进行的全部囊胚期冻融胚胎移植周期。
  • 共纳入5791个FET周期,按内膜准备方案分为AC组2226个、NPP组349个、NC组3216个。
  • 采用多变量广义估计方程回归分析校正以下潜在混杂因素:取卵时卵母细胞年龄、卵母细胞来源(自体未行PGT-A vs 自体行PGT-A vs 供卵)、取卵/供卵数、胚胎发育阶段(第5天 vs 第6天)、移植胚胎数、移植最佳胚胎质量及治疗年份。

主要发现

  • 活产率:AC组38.4% vs NPP组49.1% vs NC组45.2%(P<0.01,AC vs NPP及AC vs NC)。
  • 流产率:NPP组19.7% vs AC组34.9% vs NC组25.0%(P<0.01,NPP vs AC及NC vs AC)。
  • 早期妊娠出血率:NPP组17.3% vs AC组37.6% vs NC组14.7%(P<0.01,NPP vs AC及NC vs AC)。
  • 妊娠期高血压疾病发生率:NC组8.6% vs AC组14.5%(P<0.01),NPP-FET组为9.4%。

关键数值与推荐

  • NPP-FET方案:在增殖期一旦发现内膜厚度至少7 mm且排除排卵,即开始阴道孕酮,无论优势卵泡平均直径如何。

临床怎么用

  • NPP-FET方案可能作为NC和AC的替代选择,便于患者随访和FET周期安排。
  • 作者认为NPP-FET可能有效且安全,但需进一步前瞻性研究验证。

局限性

  • 本研究受限于回顾性设计。
  • NPP亚组患者数量少,可能导致研究不足以检测亚组间具有临床意义的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How does a natural proliferative phase (NPP) strategy for frozen embryo transfer (FET) compare with the conventional artificial (AC) and natural (NC) endometrial preparation protocols in terms of live birth rates (LBR)? SUMMARY ANSWER: This study supports the hypothesis that, just as for NC, NPP-FET may be a superior alternative to AC in terms of LBR. WHAT IS KNOWN ALREADY: Although FETs are increasing worldwide, the optimal FET protocol is still largely controversial. Despite recent evidence supporting a possibly higher efficacy and safety of NC FETs, their widespread use is limited by the difficulties encountered during cycle monitoring and scheduling. STUDY DESIGN, SIZE, DURATION: In this single center retrospective cohort study, we describe the NPP-FET protocol, in which vaginal progesterone is initiated during the proliferative phase as soon as an endometrium with a thickness of at least 7 mm is identified and ovulation is ruled out, regardless of mean diameter of the dominant follicle. PARTICIPANTS/MATERIALS, SETTING, METHODS: For comparison, we considered all blastocyst stage FET cycles preformed at a private infertility center between January 2010 and June 2022, subdivided according to the following subgroups of endometrial preparation: AC, NPP, and NC. We performed multivariable generalized estimating equations regression analysis to account for the following potential confounding variables: oocyte age at retrieval, oocyte source (autologous without preimplantation genetic testing for aneuploidies (PGT-A) versus autologous with PGT-A versus donated), number of oocytes retrieved/donated, embryo developmental stage (Day 5 versus Day 6), number of embryos transferred, quality of the best embryo transferred, and year of treatment. The main outcome measure was LBR. The secondary outcomes included hCG positive, clinical pregnancy and miscarriage rates, and the following perinatal outcomes: first trimester bleeding, second/third trimester bleeding, preterm rupture of membranes, gestational diabetes, gestational hypertensive disorders (GHD), and gestational age at delivery. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 5791 FET cycles were included in this analysis (2226 AC, 349 NPP, and 3216 NC). The LBR for FET was lower in the AC subgroup when compared to the NPP and NC (38.4%, 49.1%, and 45.2%, respectively; P < 0.01 AC versus NPP and AC versus NC). The rates of miscarriage were also lower in the NPP and NC subgroups when compared to AC (19.7%, 25.0%, and 34.9%, respectively; P < 0.01 NPP versus AC and NC versus AC). Considering perinatal outcomes, NPP-FET and NC were associated with a significantly lower first trimester bleeding compared to AC (17.3%, 14.7%, and 37.6%, respectively; P < 0.01 NPP versus AC and NC versus AC). Additionally, NC was associated with a lower rate of GHD when compared with AC (8.6% versus 14.5%, P < 0.01), while the rate following NPP-FET was 9.4%. LIMITATIONS, REASONS FOR CAUTION: This study is limited by its retrospective design. Moreover, there was also a low number of patients in the NPP subgroup, which may have led the study to be underpowered to detect clinically relevant differences between the subgroups. WIDER IMPLICATIONS OF THE FINDINGS: Our study posits that the NPP-FET protocol may be an effective and safe alternative to both NC and AC, while still allowing for enhanced practicality in patient follow-up and FET scheduling. Further investigation on NPP-FET is warranted, with prospective studies including a larger and more homogeneous subsets of patients. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the IVI-RMA-Lisbon (2008-LIS-053-CG). The authors did not receive any funding for this study. The authors have no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Mendes Godinho C, Soares SR, Nunes SG, et al. Natural proliferative phase frozen embryo transfer-a new approach which may facilitate scheduling without hindering pregnancy outcomes. Hum Reprod. 2024. PMID: 38531673. doi:10.1093/humrep/deae061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。